Search

INTRODUCTION: The use of cardiovascular magnetic resonance (CMR) for diagnosis and management of a broad range of cardiac and vascular conditions has quickly expanded worldwide. It is essential to understand how CMR is utilized in different regions around the world and the potential practice differences between high-volume and low-volume centers. METHODS: CMR practitioners and developers from around the world were electronically surveyed by the Society for Cardiovascular Magnetic Resonance (SCMR) twice, requesting data from 2017. Both surveys were carefully merged, and the data were curated professionally by a data expert using cross-references in key questions and the specific media access control IP address. According to the United Nations classification, responses were analyzed by region and country and interpreted in the context of practice volumes and demography. RESULTS: From 70 countries and regions, 1092 individual responses were included. CMR was performed more often in academic (695/1014, 69%) and hospital settings (522/606, 86%), with adult cardiologists being the primary referring providers (680/818, 83%). Evaluation of cardiomyopathy was the top indication in high-volume and low-volume centers (p = 0.06). High-volume centers were significantly more likely to list evaluation of ischemic heart disease (e.g., stress CMR) as a primary indicator compared to low-volume centers (p

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.

Women's engagement in medicine, and more specifically cardiovascular imaging and cardiovascular MRI (CMR), has undergone a slow evolution over the past several decades. As a result, an increasing number of women have joined the cardiovascular imaging community to contribute their expertise. This collaborative work summarizes the barriers that women in cardiovascular imaging have overcome over the past several years, the positive interventions that have been implemented to better support women in the field of CMR, and the challenges that still remain, with a special emphasis on women physicians.

This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.

This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR. © 2021, The Author(s).

CIES2020 - XVII Congresso Ibérico e XIII Congresso Ibero-americano de Energia Solar RESUMEN: Este trabajo evalúa el efecto que tiene la integración de materiales de cambio de fase (MCF) en la envolvente de los edificios, sobre la operación de un sistema de generación solar fotovoltaica acoplado con bomba de calor para cubrir las necesidades térmicas de dicho edificio. A partir de una instalación a escala real, se han realizado modelos en EnergyPlus de diferentes escenarios de estudio intermedios, teniendo en cuenta que la aplicación de los MCF microencapsulados como revestimiento de paredes interiores, requiere de un material de sustrato y un mortero para que se incorpore, evaluando de esta forma el efecto que tiene cada uno de los elementos. Se ha simulado y evaluado el efecto en cada escenario de estudio sobre la demanda energética del demostrador, desde la solución constructiva del fabricante hasta la solución con el mortero aditivado con MCF aplicado como recubrimiento interior de las paredes. En paralelo se ha realizado la simulación mediante TRNSYS de una instalación fotovoltaica de 50, 100, 200 y 300 W conectadas a una bomba de calor sobre la que se ha considerado que tiene un rendimiento en calefacción de 3 y un rendimiento de refrigeración de 2. Los resultados muestran que hay una gran cantidad de energía de calefacción que se pierde en los momentos en los que la demanda de calefacción es reducida y la disponibilidad de energía solar es alta. También se ha podido comprobar que el dimensionado para refrigeración es más crítico que para calefacción. Finalmente cabe indicar que el presente trabajo se ha realizado dentro del marco del proyecto SUDOKET financiado por la convocatoria Interreg SUDOE. ABSTRACT: The present work evaluates the effect that the incorporation of Phase Change Materials (PCM) in the building envelope has in the operation of a solar photovoltaic (PV) generation system coupled with a heat pump for covering the thermal demand of a building. Based on data from a real scale facility, the EnergyPlus models of different case scenarios have been performed, taking into account that the application of microencapsulated PCM as an interior wall coating requires a substrate material and a mortar matrix to be embedded into. The effect on each case scenario on the buildings energy demand, from the manufacturer constructive walls solution until the PCM enhanced mortar applied as the interior wall coating, has been simulated and evaluated. In parallel, the TRNSYS simulation of a solar photovoltaic (PV) system has been performed, considering 50, 100, 200 and 300 W connected to a heat pump with a heating performance of 3 and a cooling performance of 2. The obtained results show that there is a large amount of heating energy that is wasted when the demand for heating is low and the availability of solar energy is high. It has also been demonstrated that sizing for cooling is more critical than for heating. Finally, it should be indicated that this work has been carried out within the SUDOKET project financed by the Interreg SUDOE programme. info:eu-repo/semantics/publishedVersion

The presentation and identification of cardiovascular disease in women pose unique diagnostic challenges compared to men, and underrecognized conditions in this patient population may lead to clinical mismanagement.This article reviews the sex differences in cardiovascular disease, explores the diagnostic and prognostic role of cardiovascular magnetic resonance (CMR) in the spectrum of cardiovascular disorders in women, and proposes the added value of CMR compared to other imaging modalities. In addition, this article specifically reviews the role of CMR in cardiovascular diseases occurring more frequently or exclusively in female patients, including Takotsubo cardiomyopathy, connective tissue disorders, primary pulmonary arterial hypertension and peripartum cardiomyopathy. Gaps in knowledge and opportunities for further investigation of sex-specific cardiovascular differences by CMR are also highlighted.